| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 4 297-308, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
XR Bustelo, SD Rubin, KL Suen, D Carrasco and M Barbacid
Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
We have examined the expression of the vav protooncogene during mouse embryogenesis using RNase protection assays, in situ hybridization, and immunocytochemical analysis. vav gene transcripts were first detected in E11.5 embryos in the blood-forming islands and megakaryocytes of the fetal liver. During diversification of hematopoietic activity in the embryo, vav gene expression became down-regulated in the liver and activated in thymus and spleen. In newborn animals, vav expression was also confined to hematopoietic tissues, with the exception of the ameloblastic cell layer at the latest stages of tooth morphogenesis. In the adult, vav transcripts were found in spleen, thymus, lymph nodes, and bone marrow, but not in liver. In spleen, vav transcripts were concentrated in the white pulp areas, whereas in the red pulp, the vav transcripts appeared to be primarily localized in the megakaryocytes. In thymus, vav expression was found to be more abundant in the cortical areas than in the medulla. In agreement with these observations, purified thymic lymphocytes showed heterogeneous immunoreactivity against the Vav protein, whereas splenic lymphocytes and bone marrow-derived cells displayed rather uniform levels of expression. These observations suggest that the vav protooncogene plays an important role in the signal transduction pathways that regulate the development and maintenance of the hematopoietic system.
This article has been cited by other articles:
![]() |
S. Ruiz, A. Castro-Castro, and X. R. Bustelo CD147 Inhibits the Nuclear Factor of Activated T-cells by Impairing Vav1 and Rac1 Downstream Signaling J. Biol. Chem., February 29, 2008; 283(9): 5554 - 5566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inabe, M. Ishiai, A. M. Scharenberg, N. Freshney, J. Downward, and T. Kurosaki Vav3 Modulates B Cell Receptor Responses by Regulating Phosphoinositide 3-Kinase Activation J. Exp. Med., January 14, 2002; 195(2): 189 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
C V Clevenger and J B Kline Prolactin receptor signal transduction Lupus, October 1, 2001; 10(10): 706 - 718. [Abstract] [PDF] |
||||
![]() |
P. A. Marignani and C. L. Carpenter Vav2 is required for cell spreading J. Cell Biol., July 9, 2001; 154(1): 177 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. López-Lago, H. Lee, C. Cruz, N. Movilla, and X. R. Bustelo Tyrosine Phosphorylation Mediates Both Activation and Downmodulation of the Biological Activity of Vav Mol. Cell. Biol., March 1, 2000; 20(5): 1678 - 1691. [Abstract] [Full Text] |
||||
![]() |
S. Ogilvy, D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival PNAS, December 21, 1999; 96(26): 14943 - 14948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogilvy, D. Metcalf, L. Gibson, M. L. Bath, A. W. Harris, and J. M. Adams Promoter Elements of vav Drive Transgene Expression In Vivo Throughout the Hematopoietic Compartment Blood, September 15, 1999; 94(6): 1855 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Song, H. Haleem-Smith, R. Arudchandran, J. Gomez, P. M. Scott, J. F. Mill, T.-H. Tan, and J. Rivera Tyrosine Phosphorylation of Vav Stimulates IL-6 Production in Mast Cells by a Rac/c-Jun N-Terminal Kinase-Dependent Pathway J. Immunol., July 15, 1999; 163(2): 802 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Gringhuis, L. F. M. H. de Leij, P. J. Coffer, and E. Vellenga Signaling through CD5 Activates a Pathway Involving Phosphatidylinositol 3-Kinase, Vav, and Rac1 in Human Mature T Lymphocytes Mol. Cell. Biol., March 1, 1998; 18(3): 1725 - 1735. [Abstract] [Full Text] |
||||
![]() |
S. Ogilvy, A. G. Elefanty, J. Visvader, M. L. Bath, A. W. Harris, and J. M. Adams Transcriptional Regulation of vav, a Gene Expressed Throughout the Hematopoietic Compartment Blood, January 15, 1998; 91(2): 419 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Bonnefoy-Berard, A Munshi, I Yron, S Wu, T. Collins, M Deckert, T Shalom- Barak, L Giampa, E Herbert, J Hernandez, et al. Vav: function and regulation in hematopoietic cell signaling Stem Cells, May 1, 1996; 14(3): 250 - 268. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |